Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07457333
Eligibility Criteria:
Inclusion Criteria:
* Aged 18 to 75 years, regardless of gender.
* Confirmed diagnosis of spontaneous aneurysmal subarachnoid hemorrhage (aSAH) by head CT or cerebral angiography (DSA/CTA).
* Time from symptom onset to planned first dose administration within 48 hours.
* Aneurysm successfully secured by surgical clipping or endovascular intervention.
* World Federation of Neurosurgical Societies (WFNS) grade I-III.
* Written informed consent signed by the patient or their legal representative.
Exclusion Criteria:
* Non-aneurysmal SAH (e.g., caused by trauma, arteriovenous malformation, etc.).
* Secondary to other severe intracranial diseases (e.g., large intracerebral hematoma, severe brain herniation).
* Complicated with severe cardiac, hepatic, renal, or hematopoietic system dysfunction (as defined by specific laboratory criteria).
* Known allergy to Gastrodia elata or any of its components.
* Pregnancy or breastfeeding.
* Participation in another interventional clinical trial within 30 days prior to enrollment.
* Any other condition that, in the judgment of the investigator, makes the patient unsuitable for participation in this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07457333
Study Brief:
Protocol Section:
NCT07457333